A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial

Pepine, CJ; Handberg, EM; Cooper-Dehoff, RM; Marks, RG; Kowey, P; Messerli, FH; Mancia, G; Cangiano, JL; Garcia-Barreto, D; Keltai, M; Erdine, S; Bristol, HA; Kolb, HR; Bakris, GL; Cohen, JD; Parmley, WW

doi:10.1001/jama.290.21.2805

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial

Atıf İçin Kopyala

Pepine C., Handberg E., Cooper-Dehoff R., Marks R., Kowey P., Messerli F., ...Daha Fazla

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.290, sa.21, ss.2805-2816, 2003 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 290 Sayı: 21
Basım Tarihi: 2003
Doi Numarası: 10.1001/jama.290.21.2805
Dergi Adı: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2805-2816
İstanbul Üniversitesi Adresli: Hayır

Özet

Context Despite evidence of efficacy of anti hypertensive agents in treating hypertensive patients, safety and efficacy of anti hypertensive agents for coronary artery disease (CAD) have been discerned only from subgroup analyses in large trials.